Abstract:Abstract Introduction: The loss of the antiproliferative responsiveness to TGF-β is often considered as a major step in tumor progression, thus allowing an increased and “uncontrolled” proliferation of many tumor cells. Smad4 is mutated or deleted in 55% of pancreatic cancers . However, what exact role Smad4 plays in TGF-β-mediated growth control of pancreatic ductal cancer cells remains unclear. Furthermore, status of Smad2/3 and Smad2 phosphorylation has never been analyzed in pancreatic cells. In this study, we seek to examine the essential role of Smad4 and of Smad2 phosphorylation in TGF-β-mediated growth arrest in pancreatic cancer cells. Methods: Expression of endogenous Smad2, Smad3, and Smad4 were examined by using Western blot in seven pancreatic ductal cell lines Panc1, Colo357, BxPC-3, CAPAN1, HS766T, Su86.86 and MiaPaCa2. Phosphorylation of Smad2 was immuno-detected by using anti-phospho-Smad2 antibodies after cells received TGF-β treatment. Cell growth was assessed by measuring DNA synthesis rate via 3H-thymindine incorporation. Transcription of cell cycle inhibitor p15 was analyzed by luciferase reporter assays. Results: Smad4 was only present in Panc1, Colo357 and MiaPaCa2 cells, while Smad2 and Smad3 were expressed in all cell lines tested. Upon TGF-β treatment, all cell lines except MiaPaCa2 showed a Smad2 phosphorylation, in agreement with reported loss of type II TGF-β receptor in MiaPaCa2 cells. This supports the notion that phosphorylation of Smad2 is an event prior to its interaction with Smad4. Importantly, we observed that TGF-β induced inhibition of DNA synthesis by 50–70% in Panc1 and Colo357 cells, by 15% in BxPc3 cells, and it had no inhibition in other cell lines. Accordingly, transcription of the p15 gene was induced by TGF-β in Colo357 cells. These results suggest that TGF-β-induced growth arrest was closely correlated with Smad2 phosphorylation and the presence of Smad4. Conclusion: Our data suggest that loss of Smad2 phosphorylation and functional Smad4 lead to abrogation of TGF-β-mediated tumor suppressing functions and thus contribute to pancreatic tumorigenesis.

Secreted Phosphoprotein 24 Kd (spp24) Inhibits Growth of Human Pancreatic Cancer Cells Caused by Bmp-2

Secreted Phosphoprotein 24kd (spp24) Inhibits Growth of Hepatocellular Carcinoma in Vivo.

Regulation of BMP2K in AP2M1-mediated EGFR Internalization During the Development of Gallbladder Cancer

Selenium-Binding Protein 1 May Decrease Gastric Cellular Proliferation And Migration

Biological Roles of Human Bone Morphogenetic Protein 9 in the Bone Microenvironment of Human Breast Cancer MDA-MB-231 Cells.

Inhibition of Bone Morphogenetic Protein Receptor 2 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating GRB2/PI3K/AKT Axis

BMP9 Inhibits Proliferation and Metastasis of HER2-positive SK-BR-3 Breast Cancer Cells Through ERK1/2 and PI3K/AKT Pathways.

Effect of a Bone Morphogenetic Protein-2-derived peptide on the expression of tumor marker ZNF217 in osteoblasts and MCF-7 cells

SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation

Original Protein tyrosine phosphatase PTPN2 regulates TGF- signaling through Smad4 dephosphorylation

TGF-β inhibits growth of pancreatic ductal epithelial cells through receptor-mediated activation of Smad proteins

BMP2 Inhibits TGF-β-induced Pancreatic Stellate Cell Activation and Extracellular Matrix Formation.

The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation

BMP2 as a promising anticancer approach: functions and molecular mechanisms

BMP2 induces PANC-1 cell invasion by MMP-2 overexpression through ROS and ERK.

Bone Morphogenetic Protein-10 Suppresses the Growth and Aggressiveness of Prostate Cancer Cells Through a Smad Independent Pathway.

Downregulation of Smurf2 ubiquitin ligase in pancreatic cancer cells reversed TGF-β-induced tumor formation

Bone Morphogenetic Protein‐2 Promotes Osteosarcoma Growth by Promoting Epithelial‐mesenchymal Transition (EMT) Through the Wnt/β‐catenin Signaling Pathway

Inhibition of Transforming Growth Factor β Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness

Secreted BMP Antagonists and Their Role in Cancer and Bone Metastases.

Inhibiting Β-Catenin by Β-Carboline-type MDM2 Inhibitor for Pancreatic Cancer Therapy